Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

Share Price is delayed by 15 minutes
Get Live Data
150.40    -2.20 (-1.44%)
Bid:
150.90
Ask:
151.10
Spread: 0.20 (0.133%)
Market Cap: £1.11b
GRI Live PriceLast checked at - London Stock Exchange

Intraday Grainger plc Share Chart

Statement re Possible Offer

29 Mar 2010 16:52

RNS Number : 3703J
Grainger PLC
29 March 2010
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

29 March 2010

 

Grainger plc ("Grainger") - Statement re possible offer for Sovereign Reversions plc ("Sovereign Reversions")

Grainger notes the announcement by Sovereign Reversions earlier today and confirms that it has made a preliminary approach to the Board of Sovereign Reversions with a view to entering into discussions about a possible offer for Sovereign Reversions. Grainger currently envisages making an offer at 185p in cash per Sovereign Reversions share. An offer at this level would represent a premium of 51% to the Sovereign Reversions closing price on 26 March 2010 (the last business day prior to the announcement by Sovereign Reversions of a possible offer approach).

Grainger would like to emphasize that there can be no certainty that an offer for Sovereign Reversions will be forthcoming. A further announcement will be made in due course if appropriate.

Pursuant to Rule 2.4 (c) of the Code, Grainger reserves the right to reduce the level of this possible offer if Sovereign Reversions pays a dividend or makes any other distribution to its shareholders in which case Grainger would make an equivalent reduction. Grainger also reserves the right to reduce the level of this possible offer with the recommendation of the Board of Sovereign Reversions. In addition, Grainger reserves the right to introduce other forms of consideration in substitution for all or part of the cash consideration.

This announcement does not constitute an announcement of a firm intention to make an offer under Rule 2.5 of The City Code on Takeovers and Mergers (the "Code").

 

Enquiries:

Grainger

Andrew Cunningham, Chief Executive

Dave Butler

 

Tel: +44 (0)20 7495 4700

 

J.P. Morgan Cazenove 

Robert Fowlds

Tel: +44 (0)20 7588 2828

Bronson Albery

 

Financial Dynamics

Stephanie Highett

Tel: +44 (0) 20 7831 3113

Dido Laurimore

 

The release, distribution or publication of this announcement in jurisdictions other than the UK may be restricted by law and therefore any persons who are subject to the laws of any jurisdiction other than the UK should inform themselves about and observe any applicable requirements.

J.P. Morgan plc, which conducts its UK investment banking businesses as J.P. Morgan Cazenove and is authorised and regulated in the United Kingdom by the FSA, is acting as financial adviser to Grainger and no-one else in connection with the contents of this announcement and will not be responsible to any person other than Grainger for providing the protections afforded to customers of J.P. Morgan plc nor for providing advice in relation to any matter referred to herein.

Dealing Disclosure Requirements

Under the provisions of Rule 8.3 of the Code, if any person is, or becomes, "interested" (directly or indirectly) in 1 per cent. or more of any class of "relevant securities" of Sovereign Reversions, all "dealings" in any "relevant securities" of that company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3:30pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Sovereign Reversions, they will be deemed to be a single person for the purpose of Rule 8.3.

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Sovereign Reversions by Grainger or Sovereign Reversions, or by any of their respective "associates", must be disclosed by no later than 12:00 noon (London time) on the London business day following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Panel's website at www.thetakeoverpanel.org.uk.

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OFDEASDNASEEEFF
Date   Source Headline
7th Mar 202312:46 pmRNSDirector/PDMR Shareholding
15th Feb 20231:35 pmRNSDirector/PDMR Shareholding
8th Feb 20234:16 pmRNSResult of AGM
8th Feb 20237:00 amRNSTrading Update
7th Feb 202312:12 pmRNSDirector/PDMR Shareholding
7th Feb 202312:08 pmRNSDirector/PDMR Shareholding
6th Feb 20233:14 pmRNSTotal Voting Rights
20th Jan 20235:12 pmRNSAGM Statement
12th Jan 202312:16 pmRNSTotal Voting Rights
10th Jan 20232:33 pmRNSDirector/PDMR Shareholding
13th Dec 20221:49 pmRNSDirector/PDMR Shareholding
13th Dec 20221:46 pmRNSDirector/PDMR Shareholding
8th Dec 202210:36 amRNSDirectorate Change
7th Dec 20221:33 pmRNSDirector/PDMR Shareholding
6th Dec 202211:47 amRNSTotal Voting Rights
21st Nov 20221:12 pmRNSDividend Declaration
17th Nov 20227:00 amRNSFinal Results
14th Nov 20227:00 amRNSBoard Appointment
7th Nov 20222:47 pmRNSDirector/PDMR Shareholding
11th Oct 20223:00 pmRNSDirector/PDMR Shareholding
6th Oct 20223:12 pmRNSBlock listing Interim Review
29th Sep 20223:20 pmRNSDirector/PDMR Shareholding
29th Sep 202211:08 amRNSTotal Voting Rights
20th Sep 20221:23 pmRNSDirector Declaration
12th Sep 20227:00 amRNSTRADING UPDATE
12th Sep 20227:00 amRNSTrading Update
7th Sep 20222:31 pmRNSTotal Voting Rights
6th Sep 202212:29 pmRNSDirector/PDMR Shareholding
17th Aug 20222:49 pmRNSHolding(s) in Company
8th Aug 20222:34 pmRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSCapital Markets Event
4th Jul 20223:33 pmRNSHolding(s) in Company
23rd Jun 20227:00 amRNSAcquisition
14th Jun 20222:22 pmRNSAdditional Listing
8th Jun 20223:06 pmRNSDirector/PDMR Shareholding
25th May 202210:00 amRNSHolding(s) in Company
12th May 20227:00 amRNSHalf Year Financial Results
6th May 202210:48 amRNSDirector/PDMR Shareholding
21st Apr 20222:15 pmRNSHolding(s) in Company
7th Apr 202212:01 pmRNSDirector/PDMR Shareholding
1st Apr 202212:08 pmRNSBlock listing Interim Review
25th Mar 20227:00 amRNSNotice of Interim Results
7th Mar 202212:05 pmRNSDirector/PDMR Shareholding
3rd Mar 202212:12 pmRNSTotal Voting Rights
3rd Mar 202212:08 pmRNSHolding(s) in Company
18th Feb 202211:07 amRNSDirector/PDMR Shareholding
9th Feb 20224:00 pmRNSResult of AGM
9th Feb 20227:00 amRNSTrading Update
8th Feb 202210:10 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.